Igm Biosciences logo

Igm Biosciences share price today

(IGMS)

Igm Biosciences share price is $6.9 & ₹586.33 as on 21 Dec 2024, 2.30 'hrs' IST

$6.9

-0.15

(-2.13%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Igm Biosciences share price in Dollar and Rupees. Guide to invest in Igm Biosciences from India. Also see the sentimental analysis on Indian investors investing in Igm Biosciences. Get details on the Indian mutual funds that are investing in Igm Biosciences. Get Analyst recommendations and forecasts along with all the Igm Biosciences's financials.

Igm Biosciences share price movements

  • Today's Low: $6.78
    Today's High: $7.50

    Day's Volatility :9.58%

  • 52 Weeks Low: $6.17
    52 Weeks High: $22.50

    52 Weeks Volatility :72.57%

Igm Biosciences Returns

PeriodIgm Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-56.85%
-11.1%
0.0%
6 Months
-5.48%
-6.0%
0.0%
1 Year
-17.46%
2.7%
0.0%
3 Years
-75.59%
0.6%
-19.7%

Igm Biosciences Key Statistics

in dollars & INR

Previous Close
$7.05
Open
$6.88
Today's High
$7.4983
Today's Low
$6.78
Market Capitalization
$419.2M
Today's Volume
$419.4K
52 Week High
$22.5
52 Week Low
$6.1721
Revenue TTM
$2.9M
EBITDA
$-224.0M
Earnings Per Share (EPS)
$-3.61
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-132.11%

How to invest in Igm Biosciences from India?

It is very easy for Indian residents to invest directly in Igm Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Igm Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Igm Biosciences or IGMS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Igm Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Igm Biosciences shares which would translate to 0.123 fractional shares of Igm Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Igm Biosciences, in just a few clicks!

Returns in Igm Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Igm Biosciences investment value today

Current value as on today

₹1,19,660

Returns

₹19,660

(+19.66%)

Returns from Igm Biosciences Stock

₹17,464 (false-17.46%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Igm Biosciences

10%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Igm Biosciences on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 10% more investors are searching Igm Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Igm Biosciences

  • Baker Bros Advisors LP

    6.88%

  • T. Rowe Price Associates, Inc.

    6.75%

  • Redmile Group, LLC

    5.17%

  • Goldman Sachs Group Inc

    2.12%

  • Vanguard Group Inc

    1.50%

  • BlackRock Inc

    1.49%

Analyst Recommendation on Igm Biosciences

Buy

    66%Buy

    33%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Igm Biosciences(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
5
5
6
Sell
0
0
0

Analyst Forecast on Igm Biosciences

What analysts predicted

Upside of 185.9%

Current:

$6.90

Target:

$19.73

Insights on Igm Biosciences

  • Price Movement

    In the last 1 month, IGMS stock has moved down by -22.4%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.25M → 516.0K (in $), with an average decrease of 58.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -47.90M → -61.43M (in $), with an average decrease of 28.2% per quarter
  • IGMS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 55.5%
  • IGMS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 98.6%
  • Price to Sales

    ForIGMS every $1 of sales, investors are willing to pay $143.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Igm Biosciences Technicals Summary

Sell

Neutral

Buy

Igm Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Igm Biosciences Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Igm Biosciences Inc
-22.38%
-5.48%
-17.46%
-75.59%
-85.03%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Igm Biosciences Inc
NA
NA
NA
-3.38
-1.32
-0.37
NA
1.33
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Igm Biosciences Inc
Buy
$419.2M
-85.03%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Igm Biosciences

igm biosciences, inc., a biotechnology company, engages in the research and development of immunoglobulin m (igm) antibodies for the treatment of cancer. the company's lead product candidate is igm-2323, a bispecific igm antibody that is in phase 1 clinical trials to treat patients with b cell nhl and other b cell malignancies. it is also developing igm-8444, an igm antibody targeting death receptor 5 proteins; and igm-7354, is a bispecific igm antibody delivering interleukin-15 cytokines to pd-l1 expressing cells for use in the treatment of patients with solid and hematologic malignancies. igm biosciences, inc. has a collaboration with atreca inc. and beigene ltd. to discover, develop, and manufacture novel igm and iga antibodies targeting sars-cov-2 for the potential treatment of covid-19; and strategic research collaboration and license agreement with abcellera to discover and develop igm antibodies. the company was formerly known as palingen, inc. and changed its name to igm biosci
Organization
Igm Biosciences
Employees
198
CEO
Ms. Mary Beth Harler M.D.
Industry
Health Technology

Management People of Igm Biosciences

NameTitle
Ms. Mary Beth Harler M.D.
CEO & Director
Mr. Misbah Tahir CPA
Chief Financial Officer
Mr. TS Harigopal
Senior Vice President of Group Operations
Mr. Steven Weber
Senior VP, Corporate Controller & Principal Accounting Officer
Mr. Paul C. Graffagnino J.D.
Senior Vice President of Legal Affairs
Ms. Suzette Tauber
Chief Human Resources Officer
Dr. Angus M. Sinclair Ph.D.
Executive Vice President of Research
Dr. Lisa L. Decker Ph.D.
Chief Business Officer
Dr. Marvin S. Peterson Ph.D.
Executive Vice President of Process Development & Manufacturing
Dr. Elizabeth Haanes J.D., Ph.D.
Senior Vice President of Intellectual Property

Important FAQs about investing in Igm Biosciences from India :

What is Igm Biosciences share price today?

Igm Biosciences share price today stands at $6.90, Open: $6.88 ; Previous Close: $7.05 ; High: $7.50 ; Low: $6.78 ; 52 Week High: $22.50 ; 52 Week Low: $6.17. The stock opens at $6.88, after a previous close of $7.05. The stock reached a daily high of $7.50 and a low of $6.78, with a 52-week high of $22.50 and a 52-week low of $6.17.

Can Indians buy Igm Biosciences shares?

Yes, Indians can invest in the Igm Biosciences (IGMS) from India.

With INDmoney, you can buy Igm Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Igm Biosciences at zero transaction cost.

How can I buy Igm Biosciences shares from India?

It is very easy to buy Igm Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Igm Biosciences be purchased?

Yes, you can buy fractional shares of Igm Biosciences with INDmoney app.

What are the documents required to start investing in Igm Biosciences stocks?

To start investing in Igm Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Igm Biosciences

Today’s highest price of Igm Biosciences (IGMS) is $7.50.

Today’s lowest price of Igm Biosciences (IGMS) is $6.78.

What is today's market capitalisation of Igm Biosciences

Today's market capitalisation of Igm Biosciences IGMS is 419.2M

What is the 52 Week High and Low Range of Igm Biosciences

  • 52 Week High

    $22.50

  • 52 Week Low

    $6.17

What are the historical returns of Igm Biosciences?

  • 1 Month Returns

    -22.38%

  • 3 Months Returns

    -5.48%

  • 1 Year Returns

    -17.46%

  • 5 Years Returns

    -85.03%

Who is the Chief Executive Officer (CEO) of Igm Biosciences

Ms. Mary Beth Harler M.D. is the current Chief Executive Officer (CEO) of Igm Biosciences.